Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 366 results for "cipla"

Pharma companies increase investments for global biosimilar push

Re-stepping up their investments to tap growing opportunities in biosimilars in Europe and emerging markets, Cipla is investing about Rs 600 crore to set up a manufacturing plant for biosimilars in South Africa. While Ahmedabad-based Intas is ... Smart Investor, 1 day ago

177 images for cipla

VC Circle, 4 days ago
Siasat Daily, 1 week ago, 1 week ago
Financial Express, 1 week ago, 1 week ago, 1 week ago, 1 week ago
DeshGujarat, 4 days ago, 4 days ago
Biz Community, 1 week ago

SC upholds govt notifications capping prices of essential drugs

NEW DELHI, Oct. 22 -- In a setback to pharma majors Cipla and Dr Reddy's Laboratories, the Supreme Court on Friday upheld the validity of government notifications capping the retail prices of essential medicines in public interest. A bench, headed ...
 HT Syndication4 days ago Supreme Court upholds centre's notification capping retail price of drugs  Livemint.com4 days ago SC validates government notification of fixing retail, ceiling prices of drugs  DNA India4 days ago SC favours government in overpricing case against Cipla, Dr Reddy's  Economic Times4 days ago

Cipla Q2 PAT seen up 11.2% to Rs 406 cr: Centrum

Net Sales are expected to increase by 2.6 percent Q-o-Q (up 6.8 percent Y-o-Y) to Rs 3687 crore, according to Centrum.
 Money Control1 week ago Dube TradePort secures R1.3bn pharmaceuticals investment  Engineering News1 week ago Cipla inches up on plan to set-up first biosimilars manufacturing facility in South Africa  HT Syndication1 week ago Cipla, Granules India and INOX Leisure to see some action today  HT Syndication1 week ago

Supreme Court rules against Cipla in drug price overcharging case

In a setback for drugmaker Cipla, the Supreme Court on Friday ruled in favour of the Centre in a case involving overpricing of certain medicines by the company.
 Business Line4 days ago Cipla loses case related to overcharging in Supreme Court  PharmaBiz4 days ago Blow to Cipla; company loses court battle in drug-overcharging case  Business Standard5 days ago Cipla loses drug overcharging case  Smart Investor5 days ago

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 (SCRIPCODE: 500087)

Cities Business & Finance ACCORD FINTECH BSE Online News India, Oct. 21 -- Cipla Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation ...
 HT Syndication4 days ago


Cipla Limited's Indore facility has received an all-clear from the US Food and Drug Administration (FDA) after a year since it received warning about its deficiencies. This is expected to improve the company's position in the US and support ...
 Pharmacy Choice6 days ago Cipla's Indore unit gets US FDA establishment inspection report  PharmaBiz1 week ago Cipla Announces Africa Expansion Strategy During International AIDS Conference  Biz Community1 week ago Cipla's Indore plant cleared by FDA  Business Standard1 week ago
Money Control

Cipla spurts on receiving Establishment Inspection Report from USFDA for Indore facility

The article below represents a preview only and is not meant for reuse or republishing. India, Oct. 13 -- Cipla is currently trading at Rs. 590.15, up by 9.60 points or 1.65% from its previous closing of Rs 580.55 on the BSE. The scrip opened at ...
 HT Syndication1 week ago Cipla Receives Inspection Report From US Regulator For Indore Facility  NDTV1 week ago Cipla receives EIR Report from USFDA for Indore facility  Business Standard1 week ago Cipla falls on heavy volumes  Business Standard3 weeks ago

Cipla allots equity shares

Under ESOS
 Business Standard1 week ago Cipla Ltd approves allotment of 5193 Equity Shares  Equity Bulls1 week ago

Cipla slips 2%

The pharma company informed BSE that the Supreme Court has decided in favour of Union of India in an appeal filed against Cipla and others arising out of the judgement of the Honorable Allahabad High Court.
 India Infoline5 days ago Cipla slips 2% after losing appeal in Supreme Court  India Infoline5 days ago Cipla drops after unfavorable ruling by Supreme Court  Capital Market5 days ago CIPLA : slips 2% after losing appeal in Supreme Court  4 Traders4 days ago

Cipla receives EIR for its Indore facility

This page uses frames, but your browser doesn't
 Capital Market1 week ago BRIEF-Cipla gets EIR from USFDA for its Indore facility  Reuters UK1 week ago Cipla rises over 3% as Indore unit gets EIR from USFDA  Religare Securities1 week ago Cipla gets EIR from US FDA for Indore facility  Religare Securities1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less